Immupharma.com
Immupharma is ranked > 3,000,000 in the United States. 'ImmuPharma.'
--Rank in United States
6,354,388Worldwide Rank
| Monthly pages viewed | 3,334 | |
| Monthly visits | 2,381 | |
| Value per visitor | -- | |
| Estimated worth | $2,296.98 | |
| External links | 67 | |
| Number of pages | -- |
Last Updated: 04/14/2018 . Estimated data, read disclaimer.
Visitors
| Traffic History 90 Day Average | ||
| Worldwide Rank | 5,339,822 |  -3,035,383 |
|---|---|---|
| Daily Visitors | 39 | +100% |
| Daily Visitors Rank | 5,576,175 | -4,361,451 |
| Daily Pageviews | 0 | +30% |
| Daily Pageviews Rank | 5,451,498 | -1,344,332 |
| Pageviews Per User | 2.40 |  -30% |
Content
www.Immupharma.com
Topics: Lead Compounds, Discovery Pipeline, Management Team, and For Investors.
The estimated 42 daily visitors, each view 2.40 pages on average.
Server| Server Location | |
| 1 1 Internet Ag Baden-wurttemberg Germany 51.206883, 9.887695 | |
The programming language environment is ASP.NET. There are 2 Nameservers, ns34.1and1.co.uk, and ns33.1and1.co.uk. 1 1 Internet Ag Baden-wurttemberg is the location of the Microsoft-IIS/6 server.
IP: 82.165.55.71
Powered by: ASP.NET
Web Server: Microsoft-IIS/6
Encoding: iso-8859-1
| PING www. (82.165.55.71) 56(84) bytes of data. | |
| 64 bytes from 82.165.55.71: icmp_req=1 ttl=117 | 125 ms |
| 64 bytes from 82.165.55.71: icmp_req=2 ttl=117 | 122 ms |
| 64 bytes from 82.165.55.71: icmp_req=3 ttl=117 | 122 ms |
| --- www. ping statistics --- | |
| 3 packets transmitted, 3 received, 0% packet loss, time 2002ms | |
| rtt min/avg/max/mdev = 122.290/123.599/125.977/1.708 ms | |
| rtt min/avg/max/mdev = 122.290/123.599/125.977/1.708 ms |
A ping speed test response, is timed at 125 ms.
| Server Setup | |
| Content-Length: | 4104 |
|---|---|
| Content-Type: | text/html |
| Content-Location: | /index.html |
| Last-Modified: | -- |
| Accept-Ranges: | bytes |
| ETag: | "3caa8df999cc1:24d16" |
| Server: | Microsoft-IIS/6.0 |
| MicrosoftOfficeWebServer: | 5.0_Pub |
| X-Powered-By: | ASP.NET |
| Date: | -- |